| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.644 | 0.003 | 0.644 | Dopamine D5 antagonist | 0.348 0.004 CID_154699719 | ||
| 0.499 | 0.019 | 0.499 | MAP kinase kinase 6 inhibitor | 0.369 0.079 CID_154699719 | ||
| 0.462 | 0.004 | 0.462 | 5 Hydroxytryptamine 1F antagonist | 0.148 0.017 CID_154699719 | ||
| 0.423 | 0.009 | 0.423 | 5 Hydroxytryptamine 2 antagonist | 0.11 0.065 CID_154699719 | ||
| 0.413 | 0.005 | 0.413 | Alpha 2a adrenoreceptor antagonist | 0.082 0.047 CID_154699719 | ||
| 0.4 | 0.003 | 0.4 | Acetylcholine M4 receptor antagonist | 0.116 0.019 CID_154699719 | ||
| 0.383 | 0.002 | 0.383 | 5 Hydroxytryptamine 3A antagonist | 0.104 0.014 CID_154699719 | ||
| 0.382 | 0.004 | 0.382 | Alpha 1 adrenoreceptor agonist | 0.064 0.032 CID_154699719 | ||
| 0.386 | 0.009 | 0.386 | 5 Hydroxytryptamine 2B antagonist | 0.122 0.059 CID_154699719 | ||
| 0.389 | 0.012 | 0.389 | 5 Hydroxytryptamine antagonist | 0.134 0.057 CID_154699719 | ||
| 0.362 | 0.004 | 0.362 | 5 Hydroxytryptamine 3 antagonist | 0.13 0.012 CID_154699719 | ||
| 0.364 | 0.008 | 0.364 | 5 Hydroxytryptamine 2A antagonist | 0.086 0.055 CID_154699719 | ||
| 0.359 | 0.006 | 0.359 | Alpha 2 adrenoreceptor antagonist | 0.076 0.072 CID_154699719 | ||
| 0.343 | 0.004 | 0.343 | Alpha adrenoreceptor agonist | 0.07 0.045 CID_154699719 | ||
| 0.361 | 0.024 | 0.361 | Death-associated protein kinase 3 inhibitor | 0.195 0.077 CID_154699719 | ||
| 0.338 | 0.005 | 0.338 | Dopamine D1 antagonist | 0.105 0.023 CID_154699719 | ||
| 0.346 | 0.016 | 0.346 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.198 0.052 CID_154699719 | ||
| 0.333 | 0.007 | 0.333 | Alpha 2b adrenoreceptor antagonist | 0.093 0.082 CID_154699719 | ||
| 0.394 | 0.077 | 0.394 | 15-Lipoxygenase inhibitor | |||
| 0.314 | 0.016 | 0.314 | Protein kinase (CK1) inhibitor | |||
| 0.295 | 0.012 | 0.295 | Dopamine antagonist | |||
| 0.39 | 0.109 | 0.39 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.287 | 0.007 | 0.287 | GABA receptor agonist | 0.232 0.012 CID_154699719 | ||
| 0.284 | 0.008 | 0.284 | Alpha 1b adrenoreceptor antagonist | 0.067 0.055 CID_154699719 | ||
| 0.291 | 0.016 | 0.291 | Acetylcholine M1 receptor antagonist | 0.171 0.058 CID_154699719 | ||
| 0.253 | 0.003 | 0.253 | 5 Hydroxytryptamine 6 antagonist | 0.074 0.027 CID_154699719 | ||
| 0.283 | 0.036 | 0.283 | CDC-like kinase 4 inhibitor | |||
| 0.254 | 0.02 | 0.254 | Alpha adrenoreceptor antagonist | |||
| 0.274 | 0.045 | 0.274 | MAP-kinase-activated kinase 5 inhibitor | 0.259 0.054 CID_154699719 | ||
| 0.261 | 0.032 | 0.261 | I kappa B kinase epsilon inhibitor | |||
| 0.232 | 0.004 | 0.232 | Alpha 2 adrenoreceptor agonist | 0.066 0.035 CID_154699719 | ||
| 0.231 | 0.009 | 0.231 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.304 | 0.083 | 0.304 | Apoptosis antagonist | 0.265 0.113 CID_154699719 | ||
| 0.233 | 0.014 | 0.233 | Dopamine D2 antagonist | |||
| 0.229 | 0.01 | 0.229 | Dopamine D4 antagonist | |||
| 0.26 | 0.048 | 0.26 | Platelet aggregation inhibitor | |||
| 0.219 | 0.013 | 0.219 | 5 Hydroxytryptamine agonist | 0.127 0.026 CID_154699719 | ||
| 0.226 | 0.028 | 0.226 | Ribosomal protein S6 kinase inhibitor | |||
| 0.255 | 0.059 | 0.255 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.201 0.163 CID_154699719 | ||
| 0.239 | 0.044 | 0.239 | LIM domain kinase 1 inhibitor | |||
| 0.204 | 0.013 | 0.204 | Acetylcholine agonist | |||
| 0.206 | 0.017 | 0.206 | Alpha 2c adrenoreceptor antagonist | |||
| 0.243 | 0.06 | 0.243 | Anticonvulsant | |||
| 0.239 | 0.055 | 0.244 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.244 0.053 CID_154699719 | CID_154699719 | |
| 0.188 | 0.009 | 0.188 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.33 | 0.151 | 0.33 | MAP kinase 1 inhibitor | |||
| 0.18 | 0.004 | 0.18 | 5 Hydroxytryptamine 2 agonist | |||
| 0.18 | 0.005 | 0.18 | Acetylcholine M5 receptor antagonist | 0.065 0.036 CID_154699719 | ||
| 0.234 | 0.062 | 0.234 | Clk dual-specificity kinase inhibitor | |||
| 0.189 | 0.022 | 0.189 | Alpha 1 adrenoreceptor antagonist | |||
| 0.178 | 0.011 | 0.178 | Alpha 1d adrenoreceptor antagonist | |||
| 0.186 | 0.02 | 0.186 | Check point kinase 2 inhibitor | 0.127 0.044 CID_154699719 | ||
| 0.261 | 0.096 | 0.33 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.33 0.045 CID_154699719 | CID_154699719 | |
| 0.183 | 0.02 | 0.183 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.277 | 0.113 | 0.277 | Prostaglandin dehydrogenase inhibitor | |||
| 0.191 | 0.032 | 0.191 | Protein kinase (CK1) delta inhibitor | |||
| 0.161 | 0.005 | 0.161 | Histamine agonist | |||
| 0.174 | 0.03 | 0.174 | Antiadrenergic | |||
| 0.172 | 0.029 | 0.172 | Adrenaline antagonist | |||
| 0.211 | 0.07 | 0.211 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.147 0.114 CID_154699719 | ||
| 0.15 | 0.009 | 0.15 | Alpha 2d adrenoreceptor antagonist | 0.121 0.023 CID_154699719 | ||
| 0.164 | 0.028 | 0.164 | 5 Hydroxytryptamine 3A agonist | |||
| 0.141 | 0.01 | 0.141 | Protein kinase C iota inhibitor | 0.115 0.015 CID_154699719 | ||
| 0.261 | 0.134 | 0.261 | Calcium channel activator | |||
| 0.205 | 0.079 | 0.205 | MAP kinase kinase 2 inhibitor | |||
| 0.131 | 0.005 | 0.131 | 5 Hydroxytryptamine 2C agonist | 0.052 0.026 CID_154699719 | ||
| 0.206 | 0.086 | 0.206 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.141 | 0.027 | 0.141 | Histamine H1 receptor antagonist | |||
| 0.155 | 0.041 | 0.155 | Acetylcholine muscarinic antagonist | |||
| 0.122 | 0.008 | 0.122 | 5 Hydroxytryptamine 3 agonist | |||
| 0.194 | 0.081 | 0.194 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.151 | 0.041 | 0.151 | MAP kinase 12 inhibitor | 0.1 0.098 CID_154699719 | ||
| 0.158 | 0.049 | 0.158 | MAP3K9 inhibitor | 0.13 0.094 CID_154699719 | ||
| 0.157 | 0.049 | 0.157 | Cholinergic antagonist | |||
| 0.154 | 0.048 | 0.154 | Acetylcholine antagonist | |||
| 0.138 | 0.032 | 0.16 | Protein kinase C mu inhibitor | 0.16 0.022 CID_154699719 | CID_154699719 | |
| 0.128 | 0.026 | 0.128 | Pim-3 kinase inhibitor | |||
| 0.274 | 0.174 | 0.274 | Alpha-glucosidase inhibitor | |||
| 0.134 | 0.034 | 0.134 | Gastric antisecretory | |||
| 0.136 | 0.037 | 0.136 | Activin receptor-like kinase 4 inhibitor | |||
| 0.118 | 0.02 | 0.118 | Dopamine D3 antagonist | |||
| 0.105 | 0.01 | 0.105 | Phosphodiesterase VII inhibitor | |||
| 0.095 | 0.005 | 0.095 | Purinergic P2T antagonist | 0.045 0.01 CID_154699719 | ||
| 0.138 | 0.049 | 0.138 | Protein kinase (CK2) alpha inhibitor | |||
| 0.116 | 0.029 | 0.116 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.09 | 0.004 | 0.09 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.093 | 0.008 | 0.093 | Gonadotropin-releasing hormone receptor antagonist | |||
| 0.15 | 0.067 | 0.15 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.146 | 0.066 | 0.146 | Toll-Like receptor 9 antagonist | |||
| 0.125 | 0.045 | 0.125 | Protein kinase (CK2) inhibitor | |||
| 0.186 | 0.106 | 0.186 | Dyrk kinase inhibitor | |||
| 0.102 | 0.024 | 0.102 | Benzodiazepine agonist | 0.07 0.051 CID_154699719 | ||
| 0.147 | 0.069 | 0.147 | Activin receptor-like kinase 2 inhibitor | |||
| 0.181 | 0.104 | 0.181 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.084 | 0.007 | 0.084 | Histamine H4 receptor antagonist | |||
| 0.15 | 0.074 | 0.15 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.091 | 0.017 | 0.091 | Phosphodiesterase 1B inhibitor | |||
| 0.18 | 0.107 | 0.18 | Potassium channel blocker | |||
| 0.096 | 0.023 | 0.096 | Purinergic P2 antagonist | |||
| 0.095 | 0.023 | 0.095 | Acetylcholine M2 receptor antagonist | |||
| 0.082 | 0.012 | 0.082 | Potassium channel (Inward rectifier) blocker | |||
| 0.104 | 0.034 | 0.104 | Alpha 1a adrenoreceptor antagonist | |||
| 0.096 | 0.027 | 0.096 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.076 | 0.008 | 0.076 | Phosphodiesterase 7A inhibitor | 0.05 0.039 CID_154699719 | ||
| 0.151 | 0.083 | 0.151 | Polo-like kinase-3 inhibitor | |||
| 0.255 | 0.188 | 0.255 | DNA directed DNA polymerase inhibitor | |||
| 0.135 | 0.069 | 0.135 | Death-associated protein kinase 1 inhibitor | |||
| 0.074 | 0.008 | 0.074 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.095 | 0.034 | 0.095 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.089 | 0.03 | 0.089 | CDC7 inhibitor | |||
| 0.105 | 0.045 | 0.105 | Protein kinase C zeta inhibitor | 0.098 0.054 CID_154699719 | ||
| 0.08 | 0.022 | 0.08 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.097 | 0.041 | 0.097 | I kappa B kinase inhibitor | |||
| 0.086 | 0.031 | 0.086 | MAP kinase kinase 7 inhibitor | |||
| 0.194 | 0.139 | 0.194 | MAP kinase kinase 3 inhibitor | |||
| 0.1 | 0.045 | 0.1 | Phosphodiesterase I inhibitor | |||
| 0.106 | 0.051 | 0.106 | mTOR complex 1 inhibitor | |||
| 0.168 | 0.113 | 0.168 | EphB2 antagonist | |||
| 0.103 | 0.05 | 0.103 | Protein kinase C delta inhibitor | |||
| 0.114 | 0.062 | 0.114 | MAP kinase 13 inhibitor | |||
| 0.204 | 0.152 | 0.204 | Nootropic | |||
| 0.091 | 0.04 | 0.091 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.055 | 0.006 | 0.055 | Purinergic P2Y12 antagonist | 0.023 0.016 CID_154699719 | ||
| 0.084 | 0.035 | 0.084 | Dopamine agonist | |||
| 0.164 | 0.119 | 0.164 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.073 | 0.029 | 0.073 | I kappa B kinase 2 inhibitor | |||
| 0.253 | 0.209 | 0.253 | Cyclophilin D inhibitor | |||
| 0.052 | 0.009 | 0.052 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.197 | 0.156 | 0.197 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.069 | 0.031 | 0.069 | Glutamate (mGluR1) antagonist | |||
| 0.111 | 0.073 | 0.111 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.085 | 0.049 | 0.085 | Transforming growth factor beta 3 antagonist | |||
| 0.063 | 0.026 | 0.063 | Myc inhibitor | |||
| 0.045 | 0.008 | 0.045 | CDK4/cyclin D3 inhibitor | |||
| 0.095 | 0.059 | 0.095 | Antihistaminic | |||
| 0.146 | 0.111 | 0.146 | Platelet adhesion inhibitor | |||
| 0.062 | 0.028 | 0.062 | Glucosylceramidase inhibitor | 0.06 0.031 CID_154699719 | ||
| 0.08 | 0.046 | 0.08 | Rho-associated kinase I inhibitor | |||
| 0.073 | 0.043 | 0.073 | Check point kinase 1 inhibitor | |||
| 0.065 | 0.035 | 0.065 | Acetylcholine M3 receptor antagonist | |||
| 0.105 | 0.076 | 0.105 | Aurora-B kinase inhibitor | |||
| 0.062 | 0.033 | 0.062 | Protein kinase C theta inhibitor | |||
| 0.231 | 0.204 | 0.231 | DNA polymerase beta inhibitor | |||
| 0.073 | 0.045 | 0.073 | Protein kinase B alpha inhibitor | |||
| 0.061 | 0.036 | 0.061 | Cyclin A1 inhibitor | |||
| 0.084 | 0.059 | 0.084 | Histamine antagonist | |||
| 0.081 | 0.057 | 0.081 | Adrenaline agonist | |||
| 0.03 | 0.006 | 0.03 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.091 | 0.067 | 0.091 | Pim-1 kinase inhibitor | |||
| 0.034 | 0.012 | 0.034 | Potassium channel (Inward rectifier) 1 blocker | |||
| 0.045 | 0.024 | 0.045 | Alpha 1L adrenoreceptor agonist | |||
| 0.153 | 0.133 | 0.153 | Aryl hydrocarbon receptor agonist | |||
| 0.037 | 0.017 | 0.037 | Potassium channel small-conductance Ca-activated activator | |||
| 0.06 | 0.047 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.032 | 0.02 | 0.032 | Acetylcholine M4 receptor agonist | |||
| 0.024 | 0.012 | 0.024 | Alpha 2d adrenoreceptor agonist | |||
| 0.148 | 0.141 | 0.148 | Aldehyde oxidase inhibitor | |||
| 0.102 | 0.096 | 0.102 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.076 | 0.071 | 0.076 | GABA A receptor agonist | |||
| 0.054 | 0.049 | 0.054 | Cyclin A inhibitor | |||
| 0.124 | 0.122 | 0.124 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.016 | 0.013 | 0.016 | CDK2/cyclin A3 inhibitor | |||
| 0.009 | 0.008 | 0.009 | CXC chemokine 3 receptor agonist | |||
| 0.102 | 0.118 | 0.132 | Protein kinase C nu inhibitor | 0.132 0.081 CID_154699719 | CID_154699719 | |
| 0.103 | 0.141 | 0.121 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.121 0.115 CID_154699719 | CID_154699719 | |
| 0.008 | 0.54 | 0.051 | Plasminogen activator inhibitor | 0.051 0.047 CID_154699719 | CID_154699719 | |
| 0.002 | 0.841 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.009 CID_154699719 | CID_154699719 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |